Edition:
United States

Bioblast Pharma Ltd (ORPN.OQ)

ORPN.OQ on NASDAQ Stock Exchange Capital Market

0.99USD
1:01pm EST
Change (% chg)

$0.03 (+3.42%)
Prev Close
$0.95
Open
$1.02
Day's High
$1.05
Day's Low
$0.99
Volume
4,327
Avg. Vol
26,277
52-wk High
$5.99
52-wk Low
$0.95

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.170
Sep '17 0.00 -0.320
Jun '17 0.00 -0.496
Mar '17 0.00 -0.815
FY 2016 Dec '16 0.00 -0.939
Sep '16 0.00 -1.424
Jun '16 0.00 -1.124
Mar '16 0.00 -1.588
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.72 34.40
P/E High - Last 5 Yrs. -- 148.04 46.21
P/E Low - Last 5 Yrs. -- 47.80 24.59
Beta -- 1.08 0.91
Price to Sales (TTM) -- 49.54 6.22
Price to Book (MRQ) 1.56 10.17 5.20
Price to Tangible Book (MRQ) 1.56 13.82 6.74
Price to Cash Flow (TTM) -- 52.81 24.17
% Owned Institutions 17.02 3.75 1.77

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) -- 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 129.94 8.17
Sales (TTM) vs TTM 1 Yr. Ago -- 47.86 6.50
Sales - 5 Yr. Growth Rate -- 22.77 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago 55.85 75.89 23.27
EPS (TTM) vs TTM 1 Yr. Ago 35.03 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.50
Capital Spending - 5 Yr. Growth Rate -- 9.25 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.28
Current Ratio (MRQ) 6.96 3.43 3.10
LT Debt to Equity (MRQ) 0.00 18.73 11.49
Total Debt to Equity (MRQ) 0.00 31.43 16.03
Interest Coverage (TTM) -- -43.28 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.35 54.44
Gross Margin - 5 Yr. Avg. -- 60.59 52.36
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -109.93 13.16
Operating Margin (TTM) -- -184.87 6.07
Operating Margin - 5 Yr. Avg. -- -126.36 8.47
Pre-Tax Margin (TTM) -- -175.63 7.02
Pre-Tax Margin - 5 Yr. Avg. -- -132.51 8.71
Net Profit Margin (TTM) -- -182.37 3.12
Net Profit Margin - 5 Yr. Avg. -- -136.91 4.90
Effective Tax Rate (TTM) -- 21.48 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.58 23.84

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,652,294 873,073,486
Net Income/Employee (TTM) -- 652,908 103,486,338
Receivable Turnover (TTM) -- 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.56
Asset Turnover (TTM) 0.00 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -107.24 6.46 11.45
Return on Assets - 5 Yr. Avg. -- 5.53 12.50
Return on Investment (TTM) -119.23 9.00 14.96
Return on Investment - 5 Yr. Avg. -- 6.86 16.23
Return on Equity (TTM) -119.23 10.14 16.53
Return on Equity - 5 Yr. Avg. -- 8.39 17.37
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 6.71 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Bioblast Pharma Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 18.54%
# of Holders: 3
Total Shares Held: 622,930
3 Mo. Net Change: 13,944
# New Positions: 1
# Closed Positions: 2
# Increased Positions: 2
# Reduced Positions: 2
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.